Wallén N H, Held C, Rehnqvist N, Hjemdahl P
Department of Clinical Pharmacology, Karolinska Hospital, Stockholm, Sweden.
Eur Heart J. 1999 Jul;20(14):1039-43. doi: 10.1053/euhj.1999.1451.
Inflammatory mechanisms have been implicated in the pathogenesis of atherosclerosis. Cell adhesion molecules, expressed on endothelial cells and leukocytes, mediate transendothelial migration of leukocytes into the vessel wall, but also circulate in soluble forms. In the present study we related soluble cell adhesion molecules to the risk of suffering a cardiovascular death or a non-fatal myocardial infarction (cardiovascular death/myocardial infarction) in a substudy to the Angina Prognosis Study in Stockholm (APSIS).
Soluble intercellular adhesion molecule-1, vascular adhesion molecule-1 and E-selectin were measured in serum collected on inclusion in the APSIS study. During follow-up, seven patients suffered non-fatal myocardial infarction or cardiovascular death, whereas 86 patients were event-free. Cardiovascular death/myocardial infarction was associated with elevated intercellular adhesion molecule-1 (354+/-142 vs 282+/-62ng x ml-1;P<0.01) and vascular adhesion molecule-1 (538+/-138 vs 433+/-135ng x ml-1;P =0.05), and E-selectin levels tended to be higher (72+/-54 vs 49+/-20ng x ml-1). Clinical risk factors (history of hypertension, previous myocardial infarction, diabetes and smoking) were more abundant in the event group. Subgroup analyses showed that hypertension, smoking or male sex were associated with elevated intercellular adhesion molecule-1, whereas previous myocardial infarction or male sex were associated with elevated vascular adhesion molecule-1.
Patients with stable angina pectoris who developed cardiovascular death/myocardial infarction had elevated serum levels of soluble cell adhesion molecules, indicating increased inflammatory activity. The value of soluble cell adhesion molecules as prognostic markers in patients with stable ischaemic heart disease merits further study.
炎症机制与动脉粥样硬化的发病机制有关。细胞黏附分子在内皮细胞和白细胞上表达,介导白细胞经内皮迁移至血管壁,但也以可溶性形式循环。在本研究中,我们在斯德哥尔摩心绞痛预后研究(APSIS)的一项子研究中,将可溶性细胞黏附分子与心血管死亡或非致死性心肌梗死(心血管死亡/心肌梗死)的风险相关联。
在APSIS研究纳入时采集的血清中检测可溶性细胞间黏附分子-1、血管黏附分子-1和E-选择素。随访期间,7例患者发生非致死性心肌梗死或心血管死亡,而86例患者无事件发生。心血管死亡/心肌梗死与细胞间黏附分子-1升高(354±142对282±62ng/ml;P<0.01)、血管黏附分子-1升高(538±138对433±135ng/ml;P =0.05)相关,E-选择素水平也有升高趋势(72±54对49±20ng/ml)。事件组的临床危险因素(高血压病史、既往心肌梗死、糖尿病和吸烟)更为常见。亚组分析显示,高血压、吸烟或男性与细胞间黏附分子-1升高相关,而既往心肌梗死或男性与血管黏附分子-1升高相关。
发生心血管死亡/心肌梗死的稳定型心绞痛患者血清可溶性细胞黏附分子水平升高,表明炎症活动增加。可溶性细胞黏附分子作为稳定型缺血性心脏病患者预后标志物的价值值得进一步研究。